A Double-blind, Placebo-controlled Phase II Study of Anastrozole in Patients With Pulmonary Arterial Hypertension

Trial Profile

A Double-blind, Placebo-controlled Phase II Study of Anastrozole in Patients With Pulmonary Arterial Hypertension

Completed
Phase of Trial: Phase II

Latest Information Update: 23 Oct 2016

At a glance

  • Drugs Anastrozole (Primary)
  • Indications Pulmonary arterial hypertension
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 23 Oct 2016 New trial record
    • 07 Sep 2016 Primary endpoint (To assess the effects of anastrozole vs. placebo on tricuspid annular plane systolic excursion (TAPSE)) has been met ,according to the results published in the American Journal of Respiratory and Critical Care Medicine.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top